Filippo Merloni

422 total citations
25 papers, 235 citations indexed

About

Filippo Merloni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Filippo Merloni has authored 25 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Filippo Merloni's work include Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Treatment and Pharmacology (4 papers). Filippo Merloni is often cited by papers focused on Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Treatment and Pharmacology (4 papers). Filippo Merloni collaborates with scholars based in Italy, United Kingdom and Spain. Filippo Merloni's co-authors include Ugo De Giorgi, Caterina Gianni, Marianna Sirico, Chiara Casadei, Alberto D’Angelo, Rossana Berardi, Luca Cantini, Michela Palleschi, Samanta Sarti and Lorenzo Cecconetto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Filippo Merloni

22 papers receiving 231 citations

Peers

Filippo Merloni

ONCOL

PRM

PFM

Jennifer Kherani United States

K Govind Babu India

Daniele Presti Italy

Sara Delfanti Italy

Carmen Salvador Coloma Spain

Patricia Martín-Romano France

Eleonora Teplinsky United States

Kelsey Klute United States

Matthew Labriola United States

Roby Thomas United States

Jennifer Kherani United States

Filippo Merloni

113 ×0.9

ONCOL

65 ×0.9

45 ×0.7

104 ×1.7

PRM

23 ×1.0

PFM

Citations per year, relative to Filippo Merloni Filippo Merloni (= 1×) peers Jennifer Kherani

Countries citing papers authored by Filippo Merloni

Since Specialization

Citations

This map shows the geographic impact of Filippo Merloni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filippo Merloni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filippo Merloni more than expected).

Fields of papers citing papers by Filippo Merloni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filippo Merloni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filippo Merloni. The network helps show where Filippo Merloni may publish in the future.

Co-authorship network of co-authors of Filippo Merloni

This figure shows the co-authorship network connecting the top 25 collaborators of Filippo Merloni. A scholar is included among the top collaborators of Filippo Merloni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filippo Merloni. Filippo Merloni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Casadei, Chiara, Alberto Farolfi, Ernesto Paoletti, et al.. (2025). 86P Cardiovascular toxicities with first-line maintenance olaparib (ola) + bevacizumab (bev) in advanced ovarian cancer (aOC): A real-world analysis. ESMO Open. 10. 105215–105215.

Gianni, Caterina, Alberto Farolfi, Michela Palleschi, et al.. (2025). Hormonal Therapy In Endometriosis And Breast Cancer Risk: A Propensity Score-Matched Real-World Analysis. International Journal of Gynecological Cancer. 35(2). 101267–101267. 1 indexed citations

Vespignani, Roberto, et al.. (2025). Survey on cancer patients’ attitudes towards AI and data protection: A cross-sectional study from an Italian cancer center. International Journal of Medical Informatics. 209. 106237–106237.

Merloni, Filippo, Michela Palleschi, Caterina Gianni, et al.. (2024). Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives. Clinical & Experimental Metastasis. 41(6). 863–875.

Gianni, Caterina, Michela Palleschi, Filippo Merloni, et al.. (2024). A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors. Biomedicines. 12(10). 2183–2183. 6 indexed citations

Palleschi, Michela, Eugenio Fonzi, Emanuela Scarpi, et al.. (2024). 167P Exploring the role of rare germline variants in non-coding regions of cancer predisposition genes in triple-negative breast cancer patients. ESMO Open. 9. 103189–103189. 1 indexed citations

Sirico, Marianna, Flavia Jacobs, Chiara Molinelli, et al.. (2024). Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond. Critical Reviews in Oncology/Hematology. 200. 104404–104404. 4 indexed citations

Sirico, Marianna, Alberto D’Angelo, Caterina Gianni, et al.. (2023). Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy. Cancers. 15(3). 703–703. 63 indexed citations

Merloni, Filippo, Michela Palleschi, Caterina Gianni, et al.. (2023). Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology. Frontiers in Oncology. 13. 1083297–1083297. 6 indexed citations

10.

Merloni, Filippo, Michela Palleschi, Chiara Casadei, et al.. (2023). Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure. Therapeutic Advances in Medical Oncology. 15. 2606148–2606148. 6 indexed citations

11.

Gianni, Caterina, Michela Palleschi, Filippo Merloni, et al.. (2022). Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer. Cancers. 15(1). 96–96. 3 indexed citations

12.

Sirico, Marianna, Benedetta Conte, Milena Urbini, et al.. (2022). Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives. Critical Reviews in Oncology/Hematology. 181. 103900–103900. 14 indexed citations

13.

Gianni, Caterina, Michela Palleschi, Giuseppe Schepisi, et al.. (2022). Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment. Frontiers in Oncology. 12. 882896–882896. 23 indexed citations

14.

Pistelli, Mirco, Valentina Natalucci, Veronica Agostinelli, et al.. (2021). Abstract PD11-03: Assessing the impact of 12 months lifestyle interventions on breast cancer secondary prevention: A modeling approach. Cancer Research. 81(4_Supplement). PD11–3. 1 indexed citations

15.

Ballatore, Z., Filippo Merloni, Luca Cantini, et al.. (2021). Cancer patient perspective in the arena of COVID‐19 pandemic. Psycho-Oncology. 31(1). 39–45. 12 indexed citations

16.

Cantini, Luca, Filippo Merloni, Silvia Rinaldi, et al.. (2020). Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 151. 102974–102974. 20 indexed citations

17.

Cantini, Luca, Mirco Pistelli, Filippo Merloni, et al.. (2019). Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients. Clinical Breast Cancer. 20(1). e89–e98. 10 indexed citations

18.

Merloni, Filippo, et al.. (2019). Tailored therapy in patients treated with fluoropyrimidines: focus on the role of dihydropyrimidine dehydrogenase. Cancer Drug Resistance. 2(3). 787–802. 6 indexed citations

19.

Santinelli, Alfredo, Luca Cantini, Filippo Merloni, et al.. (2017). Stromal peritumoral and intratumoral infiltrating lymphocytes: how immunity influences prognosis in triple negative breast cancer. Annals of Oncology. 28. vi31–vi32. 3 indexed citations

20.

Merloni, Filippo, Mirco Pistelli, Luca Cantini, et al.. (2017). Role of inflammation parameters in locally advanced breast cancer: the debate is still open. Annals of Oncology. 28. vi37–vi37. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact